NO873885D0 - Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter. - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter.

Info

Publication number
NO873885D0
NO873885D0 NO873885A NO873885A NO873885D0 NO 873885 D0 NO873885 D0 NO 873885D0 NO 873885 A NO873885 A NO 873885A NO 873885 A NO873885 A NO 873885A NO 873885 D0 NO873885 D0 NO 873885D0
Authority
NO
Norway
Prior art keywords
lipase
procedure
preparation
therapeutic active
active lipases
Prior art date
Application number
NO873885A
Other languages
English (en)
Other versions
NO170316C (no
NO170316B (no
NO873885L (no
Inventor
Herve Moreau
Robert Verger
Daniel Lecat
Jean-Louis Junien
Original Assignee
Jouveinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Sa filed Critical Jouveinal Sa
Publication of NO873885D0 publication Critical patent/NO873885D0/no
Publication of NO873885L publication Critical patent/NO873885L/no
Publication of NO170316B publication Critical patent/NO170316B/no
Publication of NO170316C publication Critical patent/NO170316C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
NO873885A 1986-09-17 1987-09-16 Fremgangsmaate ved fremstilling av en lipaseekstrakt elleren lipase NO170316C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8612996A FR2603804B1 (fr) 1986-09-17 1986-09-17 Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique

Publications (4)

Publication Number Publication Date
NO873885D0 true NO873885D0 (no) 1987-09-16
NO873885L NO873885L (no) 1988-03-18
NO170316B NO170316B (no) 1992-06-29
NO170316C NO170316C (no) 1992-10-07

Family

ID=9339032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873885A NO170316C (no) 1986-09-17 1987-09-16 Fremgangsmaate ved fremstilling av en lipaseekstrakt elleren lipase

Country Status (17)

Country Link
US (1) US5075231A (no)
EP (1) EP0261016B1 (no)
JP (1) JPS6379589A (no)
KR (1) KR960011522B1 (no)
AT (1) ATE86661T1 (no)
AU (1) AU602349B2 (no)
CA (1) CA1308678C (no)
DE (1) DE3784607T2 (no)
DK (1) DK483087A (no)
ES (1) ES2053575T3 (no)
FI (1) FI87232C (no)
FR (1) FR2603804B1 (no)
IE (1) IE59972B1 (no)
IS (1) IS3251A7 (no)
NO (1) NO170316C (no)
NZ (1) NZ221568A (no)
ZA (1) ZA876322B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683549B1 (fr) * 1991-11-13 1994-11-18 Jouveinal Inst Rech Acides nucleiques codant pour la lipase gastrique de lapin et derives polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques a base de ces derniers.
FR2699179B1 (fr) * 1992-12-16 1995-01-06 Jouveinal Inst Rech Acides nucléiques codant pour la lipase gastrique de chien et dérivés polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques à base de ces derniers.
US5998189A (en) * 1992-12-16 1999-12-07 Warner-Lambert Company Polypeptide derivatives of dog gastric lipase and pharmaceutical compositions containing same
FR2733249B1 (fr) * 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6537785B1 (en) 1999-09-14 2003-03-25 Genzyme Glycobiology Research Institute, Inc. Methods of treating lysosomal storage diseases
WO2001049282A2 (en) * 2000-01-06 2001-07-12 Martek Biosciences Corporation Therapeutic preparations of highly unsaturated fatty acids
EP1149585A1 (en) * 2000-04-27 2001-10-31 Warner-Lambert Company Use of recombinant gastric lipase for treating functional dyspepsia
US6800472B2 (en) 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US6905856B2 (en) 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
DE102005010604B3 (de) * 2005-03-06 2006-07-20 Lange Uhren Gmbh Uhr
KR100828146B1 (ko) * 2006-04-28 2008-05-08 김우식 췌장 리파아제의 선택적 추출방법
EP1870649A1 (en) 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
SG186648A1 (en) 2007-02-20 2013-01-30 Aptalis Pharma Ltd Stable digestive enzyme compositions
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
EP2741766B1 (en) 2011-08-08 2015-10-07 Aptalis Pharma Limited Method for dissolution testing of solid compositions containing digestive enzymes
US10993996B2 (en) 2013-08-09 2021-05-04 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
BR112016000658A2 (pt) * 2013-11-05 2018-03-20 Allergan Pharmaceuticals International Limited pancreatina de alta atividade, processo para a preparação de pancreatina de aa tendo atividade lipásica específica de pelo menos aproximadamente 120 usp iu/mg e método de tratamento de um paciente sujeito a uma condição patológica associada com a insuficiência enzimática pandreática
CA2947998A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256150A (en) * 1964-04-20 1966-06-14 Dairyland Food Lab Method for treating malabsorption syndrome
GB1139991A (en) * 1965-07-19 1969-01-15 Armour Pharma Stabilized enzyme composition
FR6622M (no) * 1967-09-12 1969-01-13
EP0131418A1 (en) * 1983-07-01 1985-01-16 Celltech Limited Proteins, pharmaceutical compositons, genes, vectors, host organisms and processes for their production
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition

Also Published As

Publication number Publication date
IE872401L (en) 1988-03-17
FI87232C (fi) 1992-12-10
FI874038A (fi) 1988-03-18
DE3784607T2 (de) 1993-10-07
FI874038A0 (fi) 1987-09-16
EP0261016B1 (fr) 1993-03-10
FR2603804B1 (fr) 1989-10-27
IS3251A7 (is) 1987-11-30
IE59972B1 (en) 1994-05-04
JPS6379589A (ja) 1988-04-09
NO170316C (no) 1992-10-07
ES2053575T3 (es) 1994-08-01
FI87232B (fi) 1992-08-31
ZA876322B (en) 1988-03-02
KR880004084A (ko) 1988-06-01
AU7795687A (en) 1988-03-24
CA1308678C (en) 1992-10-13
US5075231A (en) 1991-12-24
DK483087D0 (da) 1987-09-15
EP0261016A1 (fr) 1988-03-23
NZ221568A (en) 1991-11-26
DE3784607D1 (de) 1993-04-15
ATE86661T1 (de) 1993-03-15
DK483087A (da) 1988-03-18
KR960011522B1 (ko) 1996-08-23
AU602349B2 (en) 1990-10-11
FR2603804A1 (fr) 1988-03-18
NO170316B (no) 1992-06-29
NO873885L (no) 1988-03-18

Similar Documents

Publication Publication Date Title
NO873885L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive lipaser og lipaseekstrakter.
DK396381A (da) Faste laegemiddelpraeparater og fremgangsmaade til deres fremstilling
NO823674L (no) Derivater av cis, endo-2-azabicyklo-(3.3.0)-oktan-3-3-karboksylsyrer, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse
HUT35521A (en) Process for preparing a pharmaceutical composition containing a purified, detixicated endotoxine and a pyridine soluble extract of a microorganism
NZ224295A (en) A method of producing native or physiologically active secondary structure in physiologically inactive proteins
YU147485A (en) Process for obtaining stable camomile extract containing high percent of active substances
DE3268160D1 (en) Medicaments based on algae, and formulations thereof
ES548889A0 (es) Un procedimiento para preparar una vacuna anti-helmintica que comprende una suspension, homogeneizado o extracto de una especie de nematodo y un vehiculo farmaceutico.
FR2584726B1 (fr) Ilexosides, extraits d'ilex mitis, procede d'extraction et compositions pharmaceutiques et cosmetiques comportant des ilexosides
JPS559021A (en) Physiologically active substance from japanese ginger, its preparation, and drug comprising it
BR6501950U (pt) Sistema para producao de extrato de soja
NO853117L (no) Fremgangsmaate ved assistert utvinning av olje.
NO883674D0 (no) 5-hydroksy-3-aminokroman-forbindelser, fremgangsmaater for deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelsene og metoder for behandling dermed.
OA08179A (fr) Bis- ((hydroxy-4 isopropyl-2 méthyl-5 phénoxy)-2 éhtyl) aminés, leur méthode de synthèse, les préparations pharmaceutiques les contenant et leur application en thérapeutique.
OA07910A (fr) Nouveaux cycloalkylamino-1 tertiobutylamino-3 propanols-2, leur méthode de préparation et leur application en thérapeutique.
NO163895C (no) Derivater av cis, endo-2-azabiscyklo-(3.3.0)-oktan-3-karboksylsyre og fremgangsmaate til deres fremstilling.
NO872687D0 (no) Superkritisk fluidekstrahering av animalavledende stoffer.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees